Tuesday, 23rd April 2024
To guardian.ng
Search

Agbami Co-venturers empower 1,500 medical, engineering scholars

By Collins Olayinka, Abuja
03 November 2016   |   1:02 am
The Agbami-coventurers is building the capacities of 1,500 scholars in medical and engineering fields through its Agbami Medical and Engineering Scholarships (AMEPS) scheme.

Scholarship

The Agbami-coventurers is building the capacities of 1,500 scholars in medical and engineering fields through its Agbami Medical and Engineering Scholarships (AMEPS) scheme.

The Director of Deepwater and Productions Sharing Contract (DPSC), Mr Jeffrey Ewing, who stated this recently in Abuja at the presentation of ambulances to the governments of Borno, Adamawa and Yobe states, commended the Federal Government for gradually returning peace to the troubled areas.

He disclosed that another set of 8,000 scholars is currently benefitting from the empowerment scheme, adding “there are another 42 students from Yobe, 85 students from Borno and 70 students from Adamawa that are presently enjoying the scholarship. We are also visible in the area of economic empowerment as we provide entrepreneurs with the necessary support in diverse areas in their entrepreneurial drive.”

Ewing, who spoke through Senator Gbenga Aluko, who is also a director in Chevron, added that the group which comprises Star Deepwater Petroleum Limited, Fanfa oil, Nigerian National Petroleum Corporation (Scholarship), Statoil and Petroleo Brasilieiro Nigeria Limited, believe that the most rewarding investment is the investment in human lives adding that the greatest assets of a nation is its people.

He hinted that Star Deepwater in collaboration with its Co-ventrurers in the Agbami field has also built 25 well-equipped chest clinics, 16 hybrid libraries and 32 science laboratories in states all over the country.

On her part, the managing director of Famfa Oil limited, Ms. Folorunsho Alakija, who was represented by Oladapo Okewole, said Famfa Oil has empowered cassava young entrepreneurs in Ondo State.

0 Comments